Browse > Article
http://dx.doi.org/10.3345/kjp.2008.51.5.546

A case of two sisters births from mother with phenylketonuria lacking mental retardation  

Ki, Chang-Seok (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sung Kyun Kwan University School of Medicine)
Kim, Jin Kyung (Department of Pediatrics, College of Medicine, Daegu Catholic University)
Publication Information
Clinical and Experimental Pediatrics / v.51, no.5, 2008 , pp. 546-550 More about this Journal
Abstract
In this untreated classic phenylketonuria (PKU) case, mental retardation is severe; however, there have been individuals- like the mother of this case- who have escaped mental retardation and all the other potential sequelae of phenylketonuria, despite having high blood phenylalanine levels, and very poor dietary control. It appears that they have nearly normal brain phenylalanine levels despite high blood phenylalanine (Phe) levels. A number of studies have now demonstrated considerable variability in blood vs. brain phenylalanine levels in phenylketonuria patients. Outcome of phenylketonuria appears to be related to brain phenylalanine levels. We report a case of "undiagnosed" maternal phenylketonuria syndrome. A female infant had low birth weight (2,400 g) with microcephaly. We examined her family and discovered that her mother was an undiagnosed phenylketonuria patient with a borderline intelligence quotient (IQ). The infant's sister, six years old, was diagnosed with phenylketonuria at the age of four years was mentally retarded and had received an operation for cleft lip and palate. the sister had also had a low birth weight (2,300 g). Her sister and mother were compound heterozygotes (mother: R243Q/Y325X; sister: Y325X/P407S). The infant and father were heterozygous carriers (baby: R243Q/ -; father: P407S/ - ).
Keywords
Phenylalanine; Phenylalanine hydroxylase; Phenylketonuria; Maternal phenylketonuria syndrome;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ramus SJ, Forrest SM, Pitt DD, Cotton RG. Genotype and intellectual phenotype in untreated phenylketonuria patients. Pediatr Res 1999;45;474-81.   DOI   ScienceOn
2 Koch R, Moats R, GuttIer F, Guldberg P, Nelson M Jr. Blood-brain phenylalanine relationships in persons with phenylketonuria. Pediatrics 2000;106:1093-6.   DOI   ScienceOn
3 Gizewska M, Cabalska B, Cyrytowski L, Nowacki P, Zekanowski C, Walczak M, et al. Different presentations of late-detected phenylketonuria in two brothers with the same R408WJRlllX genotype in the PAR gene, J Intellect Disabil Res 2003;47:146-52.   DOI   ScienceOn
4 Scriver CR Why mutation analysis does not always predict clinical consequences: explanations in the era of genornics. J Pediatr 2002:140:502-6.   DOI   ScienceOn
5 Dipple KM, McCabe ER Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics, Am J Hurn Genet 2000; 66:1729-35.   DOI   ScienceOn
6 Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, et al. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria, J Clin Invest 1999:103:1169-78.   DOI   ScienceOn
7 Guttler F, Guldberg P, Mutation analysis anticipates dietary requirements in phenylketonuria. Eur J Pediatr 2000;159 Suppl 2:S150-3.   DOI
8 Kayaalp E, Treacy E, Waters PJ, Byck S, Nowacki P, Scriver CR Human phenylalanine hydroxylase mutations and hyperphenylalaninernia phenotypes: a rnetanalysis of genotype-phenotype correlations, Am J Hum Genet 1997;61: 1309-17.   DOI   ScienceOn
9 Moats RA, Koch R, Moseley K, Guldberg P, GuttIer F, Boles RG, et al. Brain phenylalanine concentration in the management of adults with phenylketonuria. J Inherit Metab Dis 2000;23:7-14.   DOI   ScienceOn
10 Eisensrnith RC, Woo SL. Population genetics of phenylke-tonuria. Acta Paediatr Suppl 1994;407:19-26.
11 Crome L. The association of phenylketonuria with leucodystrophy, J Neurol Neurosurg Psychiatry 1962;25:149-53.   DOI
12 Levy HL, Lobbregt D, Barnes PD, Poussaint TY. Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring, J Pediatr 1996;128:770-5.   DOI   ScienceOn
13 Huether G, Kaus R, Neuhoff V. Brain development in experimental hyperphenylalaninernia: myelination, Neuropediatrics 1982:13:177-82.   DOI
14 Scriver CR, Kaufman S. Hyperphenylalaninernia; Phenyla-lanine hydroxylase deficiency. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001:1667-1724.
15 Phenylalanine hydroxylase locus database (http://www.pahdb. rncgill.ca).
16 Guldberg P, Rey F, Zschocke J, Romano V, Francois B, Michiels L, et al. A European multicenter study of phenyla-lanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 1998;63:71-9.   DOI   ScienceOn
17 Huttenlocher PR The neuropathology of phenylketonuria: human and animal studies, Eur J Pediatr 2000;159(Suppl 2):S102-6.   DOI
18 Moller HE, Weglage J, Bick U, Wiedermann D, Feldmann R, Ullrich K. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria. Pediatrics 2003;112:1580-3.
19 Lee DH, Koo SK, Lee K5, Yeon YJ, Oh HJ, Kim SW, et al. The molecular basis of phenylketonuria in Korean stational Analysis. J Hum Genet 2004;49:617-21.   DOI
20 Malamud N, Neuropathology of phenylketonuria, J Neuropathol Exp Neurol 1966:25:254-68.   DOI